(77 days)
The Countach infusion set is intended for the subcutaneous infusion of medicine, including insulin, from an infusion pump and reservoir. The set is not intended nor indicated for use with blood or blood products.
The Medtronic MiniMed Countach infusion set Model MMT-313 is a disposable, single-use infusion set intended for use with Medtronic MiniMed external micro-infusion pumps. The Countach is an infusion set that uses a cannula with a disconnect.
The design will feature improved ergonomics to achieve a low profile, pre-attached adhesive system. tubing lengths. and multiple soft cannula lengths for different body types.
The provided text describes a 510(k) premarket notification for the Medtronic MiniMed Countach Infusion set Model MMT-313. This type of submission focuses on demonstrating substantial equivalence to a legally marketed predicate device rather than providing detailed clinical study data on performance against specific acceptance criteria.
Therefore, the document does not contain the requested information regarding specific acceptance criteria for device performance, the study that proves the device meets those criteria, sample sizes, expert ground truth details, adjudication methods, MRMC studies, standalone performance studies, training set details, or how ground truth was established for training and testing.
The document primarily states:
- Intended Use: The Countach infusion set is intended for the subcutaneous infusion of medicine, including insulin, from an external infusion pump. The set is not intended nor indicated for use with blood or blood products.
- Comparison to Predicate: The Countach infusion set is stated to be "substantially similar to the lawfully marketed predicate device," the Macrsk Medical A/S Paradigm Silhouette Infusion sets Models MMT-371, 372, 373 and 374 (K972135).
- Design Features: The design will feature improved ergonomics to achieve a low profile, pre-attached adhesive system, tubing lengths, and multiple soft cannula lengths for different body types.
The FDA's review in this context is to determine if the new device is "substantially equivalent" to an already approved device, meaning it has the same intended use, technological characteristics, and raises no new safety or effectiveness questions, or if it has different technological characteristics but those do not raise new questions and the information submitted demonstrates that the device is as safe and effective as the predicate device. This process typically relies on bench testing, performance testing, and comparison of technical specifications rather than extensive clinical efficacy studies with predefined acceptance criteria as might be expected for a PMA submission or a novel device.
{0}------------------------------------------------
Medtronic MiniMed Premarket Notification-510 (k) Medtronic MiniMed Countach Model MMT-313 Infusion set
SECTION C. 510(k) Summary
OCT 2 8 2003
In accordance with the requirements of SMDA 1990, and 21 CFR 807.92, this 510(k) Summary is provided:
Submitter: Medtronic MiniMed, 18000 Devonshire St., Northridge, CA 91325
Contact: Mirielle Mengotto (818) 576-4112
Name of Device: Medtronic MiniMed Countach Infusion set Model MMT-313
Predicate Devices: Macrsk Medical A/S Paradigm Silhouette Infusion sets Models MMT-371, 372. 373 and 374 (Premarket notification K972135)
Description of the Device: The Medtronic MiniMed Countach infusion set Model MMT-313 is a disposable, single-use infusion set intended for use with Medtronic MiniMed external micro-infusion pumps. The Countach is an infusion set that uses a cannula with a disconnect.
The design will feature improved ergonomics to achieve a low profile, pre-attached adhesive system. tubing lengths. and multiple soft cannula lengths for different body types.
Intended Use of the Device: The Countach infusion set is intended for the subcutancous infusion of medicine, including insulin, from an external infusion pump. The set is not intended nor indicated for use with blood or blood products.
Comparison of the Technological Features of the New Device and Predicate Device: The Countach infusion set is substantially similar to the lawfully marketed predicate device. Both sets are intended for subcutaneous delivery of insulin from the infusion pump to the pump user and attaches proximally to a reservoir by means of a luer connector.
fm
8/8/13
Date
Gerda Resdi Manager, Regulatory Affairs Medtronic MiniMed
{1}------------------------------------------------
Image /page/1/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with its wings spread, enclosed within a circle. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged around the upper half of the circle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
OCT 2 8 2003
Ms. Mirielle Mengotto Senior Regulatory Affairs Specialist Medtronic MiniMed 18000 Devonshire Street Northridge, California 91325-1219
Re: K032485
Trade/Device Name: Medtronic MiniMed Countach Infection Set Model MMT-313 Regulation Number: 880.5440 Regulation Name: Intravascular Administration Set Regulatory Class: II Product Code: FPA, FPK Dated: August 1, 2003 Received: August 12, 2003
Dear Ms. Mengotto:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{2}------------------------------------------------
Page 2 - Ms. Mengotto
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4618. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours.
Clu
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{3}------------------------------------------------
INDICATIONS FOR USE
510(k) Number:
Device Name:
Indications for Use:
Medtronic MiniMed Countach Infusion set Model MMT-313
The Countach infusion set is intended for the subcutaneous infusion of medicine, including insulin, from an infusion pump and reservoir. The set is not intended nor indicated for use with blood or blood products.
Patricia Caucenti
(Division Sign-Off) Division of Anesthesiology, General Hospital, Infection Control, Dental Devices
510(k) Number: K032185
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use ( (Per 21 CFR 801.109)
Or
Over-the-Counter Use ________
§ 880.5440 Intravascular administration set.
(a)
Identification. An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container.(b)
Classification. Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9.